Umbilical cord blood biomarkers of neurologic injury and the risk of cerebral palsy or infant death

International Journal of Developmental Neuroscience

Volumn 29, Issue 8, 2011, Pages 917-922

  Costantine, Maged M ^a   Weiner, Steven J ⁿ   Rouse, Dwight J ^b   Hirtz, Deborah G ^o   Varner, Michael W ^c   Spong, Catherine Y ^p   Mercer, Brian M ^d,e   Iams, Jay D ^f   Wapner, Ronald J ^g   Sorokin, Yoram ^h   Thorp, John M ⁱ   Ramin, Susan M ^j   O'Sullivan, Mary J ^k   Peaceman, Alan M ^l   Simhan, Hyagriv N ^m  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

^j UNIVERSITY OF TEXAS   (United States)

^k UNIVERSITY OF MIAMI   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m UNIVERSITY OF PITTSBURGH   (United States)

ⁿ GEORGE WASHINGTON UNIVERSITY   (United States)

^o NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^p EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

Cerebral palsy; Infant death; Neuroprotection; Pregnancy; Umbilical cord biomarkers

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; MAGNESIUM SULFATE; NEURON SPECIFIC ENOLASE; PLACEBO; PROTEIN S100B;

ADULT; ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CHILD DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; INFANT; LOW BIRTH WEIGHT; MULTICENTER STUDY; NERVOUS SYSTEM INJURY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGENY; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; UMBILICAL CORD BLOOD;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBRAL PALSY; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; MULTICENTER STUDIES AS TOPIC; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 80455164686     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.06.009     Document Type: Article

References (33)

1. American College of Obstetricians and Gynecologists and the American Academy of Pediatrics (ACOG & AAP) Neonatal Encephalopathy and Cerebral Palsy: Defining the Pathogenesis and Pathophysiology 2003, American College of Obstetricians and Gynecologists, Washington, DC.
2. Buhimschi C.S., Baumbusch M.A., Dulay A.T., Oliver E.A., Lee S., Zhao G., et al. Characterization of RAGE, HMGB1, and S100 beta in inflammation-induced preterm birth and fetal tissue injury. Am. J. Pathol. 2009, 175:958-975.
3. Celtik C., Acunas B., Oner N., Pala O. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev. 2004, 26:398-402.
4. Clark S.M., Ghulmiyyah L.M., Hankins G.D. Antenatal antecedents and the impact of obstetric care in the etiology of cerebral palsy. Clin. Obstet. Gynecol. 2008, 51:775-786.
5. Distefano G., Currei S., Betta P., Li Volti G., Cilauro S., Alessandro F., et al. Perinatal asphyxia in preterm neonates leads to serum changes in protein S-100 and neuron specific enolase. Curr. Neurovasc. Res. 2009, 6:110-116.
6. Florio P., Michetti F., Bruschettini M., Lituania M., Bruschettini P., Severi F.M., et al. Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death. Lancet 2004, 364:270-272.
7. Gazzolo D., Marinoni E., Di Iorio R., Lituania M., Bruschettini P.L., Michetti F. Circulating S100β protein is increased in intrauterine growth-retarded fetuses. Pediatr. Res. 2002, 51:215-219.
8. Gazzolo D., Marinoni E., Di Iorio R., Lituania M., Bruschettini P.L., Kornacka M., et al. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch. Pediatr. Adolesc. Med. 2003, 157:1163-2116.
9. Gazzolo D., Marinoni E., Di Iorio R., Bruschettini M., Kornacka M., Lituania M., et al. Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit. Care Med. 2004, 32:131-136.
10. Gazzolo D., Florio P., Ciotti S., Marinoni E., Di I.R., Bruschettini M., et al. S100B protein in urine of preterm newborns with ominous outcome. Pediatr. Res. 2005, 58:1170-1174.
11. Hagberg B., Hagberg G., Beckung E., Uvebrandt P. Changing panorama of cerebral palsy in Sweden: VIII. Prevalence and origin in the birth year period 1991-1994. Acta Paediatr. 2001, 90:271-277.
12. Hu J., Ferreira A., Van Eldik L.J. S100B induces neuronal death through nitric oxide release from astrocytes. J. Neurochem. 1997, 69:2294-2301.
13. Kaukola T., Satyaraj E., Patel D.D., Tchernev V.T., Grimwade B.G., Kingsmore S.F., et al. Cerebral palsy is characterized by protein mediators in cord serum. Ann. Neurol. 2004, 55:186-194.
14. Lotze M.T., Zeh H.J., Rubartelli A., Sparvero L.J., Amoscato A.A., Washburn N.R., et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 2007, 220:60-81.
15. Marchi N., Cavaglia M., Fazio V., Bhudia S., Hallene K., Janigro D. Peripheral markers of blood-brain barrier damage. Clin. Chim. Acta 2004, 342:1-12.
16. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
17. Michetti F., Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine. Clin. Chem. 2002, 48:2097-2104.
18. Nagdyman N., Komen W., Ko H.K., Muller C., Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr. Res. 2001, 49:502-506.
19. Nguyen D.N., Spapen H., Su F., Schiettecatte J., Shi L., Hachimi-Idrissi S., et al. Elevated serum levels of S100-β protein and seuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit. Care Med. 2006, 34:1967-1974.
20. Paneth N., Hong T., Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin. Perinatol. 2006, 33:251-267.
21. Park E.S., Park C.I., Choi K.S., Choi I.H., Shin J.S. Overexpression of S100β protein in children with cerebral palsy or delayed development. Brain Dev. 2004, 26:190-196.
22. Perlman J.M. Interventions strategies for neonatal hypoxic-ischemic cerebral injury. Clin. Ther. 2006, 28:1353-1365.
23. Qian J., Zhou D., Wang Y.W. Umbilical artery blood S100β protein: a tool for the early identification of neonatal hypoxic-ischemic encephalopathy. Eur. J. Pediatr. 2009, 168:71-77.
24. Ramaswamy V., Horton J., Vandermeer B., Buscemi N., Miller S., Yager J. Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr. Neurol. 2009, 40:215-226.
25. Rouse D.J., Hirtz D.G., Thom E., et al. A randomized trial of magnesium sulfate for the prevention of cerebral palsy. NEJM 2008, 359:895-905.
26. Saigal S., Doyle L.W. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008, 371:261-269.
27. Schlueter C., Hauke S., Flohr A.M., Rogalla P., Bullerdiek J. Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing?. Biochim. Biophys. Acta 2003, 1630:1-6.
28. Thorngren-Jerneck K., Alling C., Herbst A., Amer-Wahlin I., Marsal K. S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr. Res. 2004, 55:406-412.
29. Verdu Perez A., Falero M.P., Arroyos A., Estevez F., Felix V., Lopez Y., et al. Blood neuronal specific enolase in newborns with perinatal asphyxia. Rev. Neurol. 2001, 32:714-717.
30. Vos P.E., Lamers K.J., Hendriks J.C., et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004, 62:1303-1310.
31. Winter S., Autry A., Boyle C., Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002, 110:1220-1225.
32. Yonekura H., Yamamoto Y., Sakurai S., Petrova R.G., Abedin M.J., Li H., et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 2003, 370:1097-1109.
33. Yoon B.H., Romero R., Park J.S., Kim C.J., Kim S.H., Choi J.H., et al. Fetal exposure to an intrauterine inflammation and the development of cerebral palsy at the age of three years. Am. J. Obstet. Gynecol. 2000, 182:675-681.